ARTICLE | Clinical News
Promedior preclinical data
May 16, 2011 7:00 AM UTC
In a mouse model of diabetic retinopathy, an intraocular injection of PRM-151 resulted in an 80% reduction in retinal neovascularization area compared to vehicle. PRM-151, the human serum amyloid P c...